ArticleScientific reports2024

MICAL2 implies immunosuppressive features and acts as an independent and adverse prognostic biomarker in pancreatic cancer.

Zhicheng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.